Evidence-Based Study to Evaluate the Clinical Effectiveness of Blue Blood Cells for Secondary Prevention in Ischemic Stroke Patients and to Expand Indications for Stroke Sequelae
SPONSOR KOREA HEALTH INDUSTRY DEVELOPMENT INSTITUTE (MINISTRY OF HEALTH AND WELFARE)
PERIOD 2022.04.01-2026.11.30
Nationwide Healthcare Database Analysis Study of clinical and economic burden of OOO in Korea
SPONSOR Global Pharmaceutical Company based in Korea
PERIOD 2022.11.10-2028.11.30
Economic Analysis of OOO for the Treatment of OOO in Korea
PERIOD 2023.05.15-2029.08.31
PERIOD 2022.04.01-2028.03.01
PERIOD 2022.02.11-2030.12.31
PERIOD 2021.12.31-2027.12.31
